Researchers conducted a nationwide cohort study using data from the Taiwan National Health Insurance database and the Taiwan ...

Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients ...

Checkpoint inhibitors are a novel breakthrough that unleash the immune system’s natural cancer-fighting abilities—mainly surveilling the body and eliminating any cancer cells it finds.

Source: Getty Images Clinicians should have a standard approach for discussing the risk of adverse events associated with immune checkpoint inhibitors, researchers say. The most common immune-related ...

Researchers think they've figured out why cancer treatments that harness a person's immune system to fight a tumor can cause ...

Researchers at the University of Michigan Rogel Cancer Center have discovered a key reason why some cancers do not respond to ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, but many patients with metastatic cancer develop resistance. Understanding the mechanisms behind this resistance is ...

The combination of THIO and Libtayo has shown promising results among patients with advanced checkpoint inhibitor-resistant ...

“Immune checkpoint inhibitors (CPIs) have demonstrated effectiveness in MCC patients, but about half of patients progess, ...

Patients with cancer who receive immune checkpoint inhibitors (ICIs) have more than twice the risk for developing psoriasis compared with those who receive other treatments. Researchers conducted a ...

-- 27% relative risk reduction of progression or death with GRANITE vs. control in all treated population (HR=0.73 [90% CI, 0.44, 1.21]) -- -- 50% relative risk reduction of progression or death with ...